Cancer chemotherapeutics as immunomodulators

This publication has 70 references indexed in Scilit:

• Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor
  International Journal of Immunopharmacology, 1985
• Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes
  Clinical Immunology and Immunopathology, 1983
• Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: Correlation with rebound overshoot immune function recovery
  Clinical Immunology and Immunopathology, 1981
• Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice
  International Journal of Immunopharmacology, 1980
• T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide
  The Journal of Experimental Medicine, 1979
• Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide
  Cellular Immunology, 1979
• Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: A spin label study
  Biochemical and Biophysical Research Communications, 1979
• The Role of Specific Suppressor T Cells in Immune Tolerance
  Immunological Reviews, 1975
• Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.
  The Journal of Experimental Medicine, 1975
• Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea Pig
  Journal of Investigative Dermatology, 1967